Yuri H. Koo

Learn More
Patients and providers may be reluctant to escalate to insulin therapy despite inadequate glycemic control. To determine the proportion of patients attaining and maintaining glycemic targets after initiating sulfonylurea and metformin oral combination therapy (SU/MET); to assess insulin initiation among patients failing SU/MET; and to estimate the glycemic(More)
OBJECTIVES Many patients with Type 2 diabetes mellitus (DM) delay and/or discontinue the use of insulin. This study determined patient-perceived barriers to the initiation of, and persistence with, insulin therapy. RESEARCH DESIGN AND METHODS Patients > or = 18 years with Type 2 DM and > or = 1 elevated HbA(1c) test result (> or = 9%) were identified from(More)
  • 1